Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Investor presentation - Compumedics Limited
Health
Compumedics Limited (CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. Geographical segments of the business include: the Americas; Australia and Asia Pacific; Europe; and the Middle East.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| +5.95% | 19 Jan 2021 |
| +7.41% | 19 Nov 2020 |
| +5.77% | 18 Nov 2020 |
| 0.00% | 29 Oct 2020 |
| 0.00% | 29 Oct 2020 |
| -2.22% | 20 Oct 2020 |
| 0.00% | 30 Sep 2020 |
| 0.00% | 30 Sep 2020 |
| +0.51% | 30 Aug 2020 |
| +0.51% | 30 Aug 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,048
SECTOR RANK
/168
SHARES OUTSTANDING
Health
Compumedics Limited (CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. Geographical segments of the business include: the Americas; Australia and Asia Pacific; Europe; and the Middle East.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:CMP is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia